Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Mansky

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Journal of Virology|December 16, 2011
Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1Carolin A Guenzel, Cécile Hérate, Erwann Le Rouzic, et al.
Journal of Virology|October 22, 2010
Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanismsZhenya Ni, David A Knorr, Christine L Clouser, et al.
The Journal of Biological Chemistry|September 16, 2018
Human T-cell leukemia virus type 1 Gag domains have distinct RNA-binding specificities with implications for RNA packaging and dimerizationWeixin Wu, Joshua Hatterschide, Yu-Ci Syu, et al.
Journal of Molecular Biology|November 14, 2021
Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2Morgan E Meissner, Nora A Willkomm, Jamie Lucas, et al.
Journal of Molecular Biology|April 24, 2026
Identification of non-basic matrix domain residues that impact HTLV-1 Gag membrane targeting and particle releaseShuyu Meng, Bao Pham, Sophie Hines, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Unconventional stabilization of the human T-cell leukemia virus type 1 immature Gag latticeMartin Obr, Mathias Percipalle, Darya Chernikova, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2012
Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1Christine L Clouser, Colleen M Holtz, Mary Mullett, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabineChristine L Clouser, Jay Chauhan, Matthew A Bess, et al.
Journal of Molecular Biology|May 1, 2022
Molecular Determinants of Human T-cell Leukemia Virus Type 1 Gag Targeting to the Plasma Membrane for AssemblyDominik Herrmann, Heather M Hanson, Lynne W Zhou, et al.
Nature Structural & Molecular Biology|September 6, 2024
Distinct stabilization of the human T cell leukemia virus type 1 immature Gag latticeMartin Obr, Mathias Percipalle, Darya Chernikova, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Journal of Virology|December 16, 2011
Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1Carolin A Guenzel, Cécile Hérate, Erwann Le Rouzic, et al.
Journal of Virology|October 22, 2010
Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanismsZhenya Ni, David A Knorr, Christine L Clouser, et al.
The Journal of Biological Chemistry|September 16, 2018
Human T-cell leukemia virus type 1 Gag domains have distinct RNA-binding specificities with implications for RNA packaging and dimerizationWeixin Wu, Joshua Hatterschide, Yu-Ci Syu, et al.
Journal of Molecular Biology|November 14, 2021
Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2Morgan E Meissner, Nora A Willkomm, Jamie Lucas, et al.
Journal of Molecular Biology|April 24, 2026
Identification of non-basic matrix domain residues that impact HTLV-1 Gag membrane targeting and particle releaseShuyu Meng, Bao Pham, Sophie Hines, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Unconventional stabilization of the human T-cell leukemia virus type 1 immature Gag latticeMartin Obr, Mathias Percipalle, Darya Chernikova, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2012
Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1Christine L Clouser, Colleen M Holtz, Mary Mullett, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabineChristine L Clouser, Jay Chauhan, Matthew A Bess, et al.
Journal of Molecular Biology|May 1, 2022
Molecular Determinants of Human T-cell Leukemia Virus Type 1 Gag Targeting to the Plasma Membrane for AssemblyDominik Herrmann, Heather M Hanson, Lynne W Zhou, et al.
Nature Structural & Molecular Biology|September 6, 2024
Distinct stabilization of the human T cell leukemia virus type 1 immature Gag latticeMartin Obr, Mathias Percipalle, Darya Chernikova, et al.
Pageof 11